ABSTRACT
Introducción: Las publicaciones científicas permiten el desarrollo científico y tecnológico sobre un área del conocimiento. Objetivo: Caracterizar la producción científica de autores con afiliación a instituciones latinoamericanas sobre ansiedad y COVID-19. Métodos: Se realizó una revisión de las publicaciones indizadas en la base de datos Scopus relacionados con la ansiedad y la COVID-19, especificando que al menos un autor tenga afiliación de un país latinoamericano. Se revisó cada artículo para seleccionar solo aquellas publicaciones que hayan estudiado estas variables. Finalmente, sus características fueron registradas y analizadas usando Microsoft Excel y el software VOSviewer. Conclusiones: La producción científica latinoamericana sobre ansiedad y COVID-19 aún es escasa, pero se encuentra en crecimiento, por lo que es importante generar alternativas para incrementar el número de redes de colaboración y producción(AU)
Introduction: Scientific publications allow scientific and technological development on an area of knowledge. Objective: To characterize the scientific production of authors affiliated to Latin American institutions on anxiety and COVID-19. Methods: A review of the publications indexed in the Scopus database related to anxiety and COVID-19 was carried out, specifying that at least one author had affiliation with a Latin American country. Each article was reviewed to select only those publications that studied these variables. Finally, their characteristics were recorded and analyzed using Microsoft Excel and VOSviewer software. Conclusions: Latin American scientific production on anxiety and COVID-19 is still scarce, but it is growing, so it is important to generate alternatives to increase the number of collaborative networks and production(AU)
Subject(s)
Humans , Male , Female , Anxiety , Scientific and Technical Publications , COVID-19/epidemiologyABSTRACT
Background: Currently, there is a worldwide health crisis due to the COVID-19 pandemic; consequently, it is necessary to find effective vaccines in order to immunize the population and prevent the transmission of the disease. Likewise, it is important to know vaccine progress and efficacy research, mainly in Latin American countries where no studies have been conducted yet to know the scientific production on COVID-19. Methods: A retrospective and descriptive study was carried out and COVID-19 vaccine publications in Scopus-indexed journals were considered as a unit of analysis for the period between 2020 and June 2021, with authors affiliated to Latin American institutions. Results: We found 141 published Scopus-indexed COVID-19 vaccine articles with authors affiliated to Latin American institutions. Brazil has the highest scientific production with 33.33%, followed by Mexico, Colombia, Argentina and Chile. Regarding productivity by institution, 137 international institutions have participated in the Latin American COVID-19 vaccine production. The journals with the highest number of published articles are Vaccines and Vaccine. Both journals are located in Q1 of the SJR. The most frequently used descriptor was coronavirus disease 2019. Conclusion: The Latin American scientific production on COVID-19 vaccines included 141 published Scopus-indexed articles. Likewise, Brazil is the Latin American country with the highest scientific production.
Subject(s)
COVID-19 Vaccines , COVID-19 , COVID-19/prevention & control , Humans , Latin America , Pandemics/prevention & control , Retrospective StudiesSubject(s)
Mental Disorders , Social Stigma , Delivery of Health Care , Health Personnel , Humans , Mental Disorders/therapyABSTRACT
Latin American scientific production related to the COVID-19 epidemic means that only 6% represent publications by Latin American authors, led by countries such as Brazil and Mexico; however, this production is still scarce, so efforts must be doubled to make a substantial contribution to the search for alternatives to address the global health crisis that is now in place.
